A new series of novel (2S)-2-({2-[1,4-dihydro-3,5-bis(methoxycarbonyl)-2,6-dimethyl-4-(2-nitrophenyl)pyridin-1-yl]-2-oxoethyl}amino)-3-(4-hydroxyphenyl) propanoic acid (3a) and its analogues 3b-j has been synthesized. These compounds were evaluated for their in vitro antioxidant activity, anti-inflammatory activity and antiulcer activity. Compounds 3b and f exhibited significant antioxidant action comparable with that of standard. Efficacy against inflammation and ulceration was also found to be significant. The chemical structures of these compounds were confirmed on the basis of spectral data.
Gastric acid secretion is a calcium dependent process and calcium channel blockers including nifedipine have exhibited good potential to reduce gastric secretion. [1] [2] [3] The role of free radicals in inflammation of gastric mucosa and use of antioxidants for protection against ulceration has been widely suggested. 4, 5) Several amino acids 6) and their conjugates with curcumin, 7) pyrrole 8) and 5H-dibenzazepine 9) have been reported with significant antioxidant action. Inspired with antisecretory profiles of nifedipine and antioxidant properties of amino acids and in connection with our research on the design and synthesis of biologically active and pharmacologically important new heterocycles, it was thought worthwhile to synthesize the amino acid conjugates of nifedipine with a view to obtain certain new chemical entities with potential to reduce excess gastric acid secretion as well as protect gastric mucosa against inflammation and ulceration. On the other hand, to the best of our knowledge, previously there is no report, on the synthesis of (2S)-2-({2-[1,4-dihydro-3,5-bis(methoxycarbonyl)-2,6-dimethyl-4-(2-nitrophenyl)pyridin-1-yl]-2-oxoethyl}amino)-3-(4-hydroxyphenyl)propanoic acid (3a) and its analogues 3b-j.
The key intermediate dimethyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate (1) was prepared by Hansch pyridine synthesis by treating 2-nitrobenzaldehyde with methyl acetoacetate in presence of ammonium hydroxide. Dimethyl 1-(2-chloroacetyl)-1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate (2) was prepared by reaction of nifedipine (1) in benzene with 3-chloroacetyl chloride in presence of triethylamine and continuous stirring. Further treatment of compound 2 with amino acids in presence of K 2 CO 3 in methanol followed by reflux yielded the title compounds 3a-j. The synthetic route leading to the title compounds is summarized in Chart 1. The chemical structures of all the newly synthesized compounds were confirmed by their IR, 1 H-NMR, elemental and mass spectra analysis. The compounds were screened for their antioxidant, anti-inflammatory and antiulcer activities.
In-Vitro Antioxidant Study The free radical scavenging activity of synthesized compounds was evaluated by the method first employed by Blois 10) using 1,1-diphenyl-2-picrylhydrazyl (DPPH). To 1 ml of each compound of different concentrations (1, 2, 3, 4, 5 mg/ml) 1 ml of 0.1 mmol DPPH was added and incubated in the dark room for 35 min. The absorbance was measured at 517 nm and percentage quenching of DPPH was calculated. For all the compounds and standard half inhibition concentration (IC 50 ) was calculated and showed in Table 1 . Conjugation of amino acids increased the antioxidant potential of nifedipine as evident from the lower IC 50 value of compounds. The IC 50 value of compound 3b was lowest among the test compounds followed by that of 3f indicating their good radical scavenging potential. The DPPH radical scavenging action of 3b was found to be better than ascorbic acid (Fig. 1) .
Anti-inflammatory Activity of Synthesized Compounds Acute inflammation was produced by sub plantar injection of 0.1 ml of 1% suspension of carrageenin in normal saline in the right hind paw of the rats. Paw volume was measured plethysmometrically 11) at 0 and 4 h after carrageenin injection. The animals were treated with the synthesized compounds (50 mg/kg). Saline (3 ml/kg, orally) treated animals served as control and acetyl salicylic acid (100 mg/kg, orally) was administered as standard drug. The drugs were administered simultaneously with carrageenin injection. Mean increase in paw volume was measured and reported in Table 1 . All the test compounds reduced the paw volume. The antiinflammatory activity was found to be significant (pϽ0.001) for compounds 3b, c and f (Fig. 2) .
Antiulcer Activity of Synthesized Compounds The antiulcer activity of the synthesized compounds were evaluated by pyloric ligature induced gastric ulcers in rat model using parameters including volume, pH, ulcer index, free acidity and total acididy.
12) The test compounds exhibited variable antiulcer activity. Reduction in acid secretion was more significant (pϽ0.001) in animals administered with compounds 3b, c and f. The acid neutralizing ability of 3b and 3f were more significant (pϽ0.001) and comparable with omeprazole. The reduction in free acidity by 3b and f was close to that of the standard. The reduction in total acidity by both compounds was significant (pϽ0.001) but less than omeprazole. The ulcer healing capacity as indicated by ulcer index was significant (pϽ0.001) for compounds 3a, d, f, h and i. This study shows that antioxidant action complements the antisecretory properties of the compounds as evident from activities of compounds 3b and f. Compound 3b showed better antioxidant action than 3f but the anti-inflammatory and antiulcer actions were comparable. Thus it can be suggested that antioxidant action of 3b has not been able to remarkably potentiate its antisecretory properties. From this study it can be proposed that conjugation of amino acids to nifedipine enhanced the antioxidant action that complemented the antisecretory action of the compounds resulting in increased anti-inflammatory and antiulcer potential. This improvement was more significant in phenyl alanine and methionine conjugates of nifedipine.
Experimental
General All reagents and solvents were used as purchased without further purification. Melting points were determined on a Sisco melting point apparatus and are uncorrected. Crude products were purified by column chromatography on silica gel of 60-120 mesh. IR spectra were obtained on a JASCO FTIR-4100 spectrometer using KBr pellet. NMR spectra were recorded on BRUKER AVANCE-II-400 MHz spectrometer for 1 H-NMR. The chemical shifts were reported as ppm down field using tetramethylsilane (TMS) as an internal standard. Elemental analysis was carried out with PERKIN ELMER-2400 analyser. Mass spectra were recorded on a MICRO-MASS Q-TOF MICRO spectrometer operating at 70 eV.
Typical Procedure Dimethyl 1,4-Dihydro-2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate (1) A solution of 2-nitro benzaldehyde (0.2 mol), methyl acetoacetate (0.2 mol) and ammonium hydroxide (8 ml) in ethanol (60 ml) was heated under reflux for 3 h. To the resulting mixture warm water (40 ml) was added and then allowed to cool. The separated product was filtered off, washed with 60% aqueous ethanol and recrystallised from ethanol. The purity of the compound was checked with TLC.
Dimethyl-1-(2-chloroacetyl)-1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate (2) Chloroacetyl chloride (2.2 mmol) was added drop by drop for about 30 min to the well stirred solution of 1 (2 mmol) and triethylamine (2.2 mmol) in 50 ml benzene. The reaction mixture was stirred at room temperature for about 6h. Progress of the reaction was monitored by TLC using 9 : 1 (hexane : ethyl acetate) mixture as mobile phase. After completion of reaction, the reaction mass was quenched in ice Vol. 59, No. 9 Chart 1 cold water and extracted in diethyl ether. The ether layer was washed twice with 5% NaHCO 3 and twice with distilled water. Finally the ether layer was dried with anhydrous Na 2 SO 4 . (2S)-2-({2-[1,4-Dihydro-3,5-bis(methoxycarbonyl)-2,6-dimethyl-4-(2-nitrophenyl)pyridin-1-yl]-2-oxoethyl}amino)-3-(4-hydroxyphenyl)- propanoic Acid (3a) Tyrosine (1.2 mmol) in methanol (25 ml) was neutralized with triethylamine (1.2 mmol). To this K 2 CO 3 (600 mg) was added. Later the solution of 2 (1 mmol) in methanol (50 ml) was added drop by drop for 30 min. The reaction mixture was refluxed for 8 h. The progress of the reaction was monitored by TLC. The reaction mixture was then desolventized and compound was extracted in ethyl acetate. The ethyl acetate layer was washed with water and dried over anhydrous Na 2 SO 4 . The product was further recrystallised from ethanol. Other compounds of the series 3a-j were obtained in a similar manner.
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